In a dextran sodium sulfate (DSS)-induced murine model of colitis, DSS treatment resulted in a significant increase in the expression levels of pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6, which play key roles in the pathogenesis of inflammatory bowel disease (IBD). Here, IL6 is linked to inflammatory bowel disease.